BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3463439)

  • 1. Apparent mineralocorticoid excess causing hypertension and hypokalemia in children.
    New MI; Stoner E; DiMartino-Nardi J
    Clin Exp Hypertens A; 1986; 8(4-5):751-72. PubMed ID: 3463439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New findings in apparent mineralocorticoid excess.
    DiMartino-Nardi J; Stoner E; Martin K; Balfe JW; Jose PA; New MI
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):49-62. PubMed ID: 2820623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
    Al-Harbi T; Al-Shaikh A
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1083-8. PubMed ID: 23329753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent mineralocorticoid excess syndromes.
    Shimojo M; Stewart PM
    J Endocrinol Invest; 1995; 18(7):518-32. PubMed ID: 9221270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.
    Stewart PM; Walker BR; Holder G; O'Halloran D; Shackleton CH
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3617-20. PubMed ID: 8530609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11 beta-Hydroxysteroid dehydrogenase deficit: a rare cause of arterial Hypertension. Diagnosis and therapeutic approach in two young brothers.
    Gourmelen M; Saint-Jacques I; Morineau G; Soliman H; Julien R; Fiet J
    Eur J Endocrinol; 1996 Aug; 135(2):238-44. PubMed ID: 8810740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Rodríguez JA
    Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
    Stewart PM; Corrie JE; Shackleton CH; Edwards CR
    J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
    Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH
    J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.
    Oberfield SE; Levine LS; Carey RM; Greig F; Ulick S; New MI
    J Clin Endocrinol Metab; 1983 Feb; 56(2):332-9. PubMed ID: 6296185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid hormones and hypertension: the cortisol-cortisone shuttle.
    Stewart PM; Whorwood CB; Walker BR
    Steroids; 1993 Dec; 58(12):614-20. PubMed ID: 8116018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent mineralocorticoid excess: type I and type II.
    Mantero F; Palermo M; Petrelli MD; Tedde R; Stewart PM; Shackleton CH
    Steroids; 1996 Apr; 61(4):193-6. PubMed ID: 8732999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
    White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
    Pediatr Res; 1997 Jan; 41(1):25-9. PubMed ID: 8979285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
    Palermo M; Shackleton CH; Mantero F; Stewart PM
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
    Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the mechanism of hypertension in apparent mineralocorticoid excess.
    Speiser PW; Riddick LM; Martin K; New MI
    Metabolism; 1993 Jul; 42(7):843-5. PubMed ID: 8393954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineralocorticoid hypertension and congenital deficiency of 11 beta-hydroxysteroid dehydrogenase in a family with the syndrome of 'apparent' mineralocorticoid excess.
    Milford DV; Shackleton CH; Stewart PM
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):241-6. PubMed ID: 7554322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
    White PC
    Am J Med Sci; 2001 Dec; 322(6):308-15. PubMed ID: 11780688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The syndrome of apparent mineralocorticoid excess.
    Cooper M; Stewart PM
    QJM; 1998 Jul; 91(7):453-5. PubMed ID: 9797927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.